Business Context and Reporting Period
This Form 10-Q covers E. I. du Pont de Nemours and Company (DuPont) for the quarterly period ended September 30, 1995. The filing details record earnings driven by cost control and favorable joint venture allocations, despite a difficult global business climate. A significant corporate event during the period was the April 1995 redemption of 156 million shares from Seagram, which reduced the share count by approximately 18% and altered the company's capital structure.
Key Financial Metrics
| Metric | Q3 1995 | Q3 1994 | 9 Months 1995 | 9 Months 1994 |
|---|---|---|---|---|
| Sales | $10,200M | $9,845M | $31,778M | $29,196M |
| Net Income | $769M | $647M | $2,666M | $2,081M |
| Earnings Per Share (EPS) | $1.38 | $0.95 | $4.47 | $3.05 |
| Cash from Operations (9M) | $4,470M (vs $4,392M prior year) | |||
| Capital Expenditures (9M) | $2,329M (vs $2,003M prior year) | |||
| Debt Ratio | 61% (Total debt to total capitalization) | |||
| Current Ratio | 0.9:1 (Current assets to current liabilities) |
Liquidity and Debt: Short-term borrowings increased significantly to $7,100 million (from $1,292 million at year-end 1994) to finance the Seagram stock redemption. Total debt rose, pushing the debt ratio to 61%. However, the company maintains $5.4 billion in unused short-term bank credit lines.
Material Changes vs. Prior Period
- Earnings Growth: Q3 1995 EPS increased 45% year-over-year. Excluding the accretion effect from the share buyback, net income increased 28%.
- Share Count Reduction: Average shares outstanding for the quarter were 18% lower than the prior year due to the Seagram redemption.
- Segment Performance:
- Chemicals: Earnings up 53% ($159M) driven by higher selling prices (+10%) and better results in white pigments.
- Fibers: Earnings up 18% ($194M) due to significant improvement in aramids.
- Polymers: Earnings up 12% ($198M) with growth in fluoropolymers and packaging.
- Petroleum: Earnings up 6% ($182M); upstream results improved due to lower costs offsetting lower gas prices.
- Diversified Businesses: Earnings up 42% ($192M), largely due to a more favorable allocation of income from the DuPont Merck joint venture.
- Accounting Change: The company switched from an accelerated to a straight-line depreciation method for nonpetroleum PP&E placed in service in 1995. Management stated this had no material impact on 1995 results.
Outlook, Risks, and Unusual Items
Guidance and Outlook: Management expects full-year 1995 capital expenditures to be approximately $3.5 billion. The company projects the debt ratio will return to about 40% by year-end 1996, aided by planned asset sales of approximately $2 billion to finance the Seagram redemption.
Credit Ratings: Following the stock redemption, Moody's lowered the senior long-term debt rating to Aa3 (from Aa2), and S&P lowered it to AA- (from AA). Both agencies affirmed commercial paper ratings. Management does not expect these changes to materially impact borrowing costs or access to capital.
Legal Proceedings and Contingencies:
- Benlate Litigation: Over 700 lawsuits filed by growers alleging crop damage. A Georgia federal court conditionally fined DuPont $115 million for discovery abuse; the company is appealing. A shareholder derivative suit is stayed pending the appeal.
- Polybutylene Plumbing: Approximately 100 homeowner lawsuits and class actions regarding leaks. DuPont has settled Texas cases (up to $34M) and a nationwide class action settlement is pending approval, with a potential funding commitment capped at $120 million.
- Environmental: Ongoing remediation at a former oil reprocessing facility in Wyoming (DuPont subsidiary CPLC) and an EPA administrative complaint regarding recordkeeping violations at the East Chicago plant.
Management Changes: Edgar S. Woolard, Jr. is retiring as CEO on December 31, 1995, to remain as Chairman. John A. Krol is succeeding him as CEO. Constantine S. "Dino" Nicandros, CEO of Conoco (DuPont's petroleum subsidiary), is retiring in February 1996.
Investor Verification Checklist
- Debt Structure: Verify the sustainability of the 61% debt ratio and the timeline for reducing it to 40% via asset sales.
- Legal Exposure: Monitor the outcome of the $115 million Benlate discovery abuse fine appeal and the final approval of the $120 million polybutylene settlement.
- Joint Venture Allocation: Assess the sustainability of the earnings boost from the DuPont Merck joint venture allocation.
- Capital Allocation: Confirm the execution of the planned $2 billion in asset sales to refinance the Seagram redemption.
- Leadership Transition: Evaluate the strategic direction under the new CEO, John A. Krol, effective December 1995.